Generational Dynamics Forum - New Site

Philippines 2024 Vital Statistics Full Release Gives Evidence of Failing Population Health! Births down 6.2%. Deaths up 1%. Infant Mortality up, Fetal Death Rate up, Maternal Mortality up.

Leading causes of death are circulatory (37.9%) including cardiovascular (19.1%) and cerebrovascular (9.8%), respiratory diseases (11.4%) of which pneumonia 6.7%, neoplasms 11%, and diabetes (6.3%).

The Philippines has released its official 2024 marriage (25Nov2025), birth (22Dec2025), and death (30Jan2026) reports. Key overall findings are presented in this article for information and reference. I will prepare some breakdown analyses of regional and cause of death data for publication in coming weeks.

2024 Population Births and Deaths

Compared to 2023, 2024 registered births fell by 6.2% while deaths rose by 1%.

There were 705,714 (51.9%) male births and 653,275 (48.1%) female births. The drop in female births between 2023 and 2024 was 6.03%, while the drop in male births was 6.3%. Total loss of births since 2012, the Philippines peak birth year, is 24.1%. The majority of this loss (18.8%) occurred between 2019 and 2025. Such a rapid loss in births is historically unprecedented, particularly considering the young population of the Philippines (median age around 26).

The WHO interferes in the EMF scientific review process reveals Meike Mevissen

As published in the Daily Sceptic on 5th February 2026

Your smartphone, your Wi-Fi, your smart meter, your iPad and much else all use radio-frequency radiation (RFR), but do you know what physical effect this is having on your and your family’s health? Where will you find the truth? Although we only ever hear publicly that RFR “should” be safe, a glimpse behind the scenes reveals a raging battle amongst scientists in an attempt to control the narrative.

This struggle comes at a time when the governments of the world are awaiting the forthcoming WHO Environmental Health Criteria monograph, which will pronounce on the health risks or otherwise of exposure to electromagnetic fields including RFR. Even more critical is the upcoming possible reclassification of RFR as a probable cancer risk by the International Agency for Research on Cancer (IARC). The stakes could not be higher.

At the centre of this battle are Meike Mevissen on one side and Ken Karipidis on the other. They are the lead authors of two of the 12 systematic reviews commissioned by the WHO EMF Project on the health effects of radio-frequency radiation (RFR). Only one of these 12 reviews was considered by experts from the International Commission on the Biological Effects of Electromagnetic Fields (ICBE-EMF) to be well-executed, and this was the one by Mevissen et al., which concluded that there is high certainty evidence that RF-EMF exposure increases the incidence of malignant schwannomas (heart tumours) and gliomas (brain tumours) in rats, with moderate certainty evidence of an increased risk of rare tumours in the adrenal glands and in the liver. This RF-EMF is just the same type of radiation that is emitted by your phone and that you hold to your head and keep in your pocket, and that is constantly by your side.

The FDA greenlit a human trial of an "immortality elixir" containing SV40!

I wish I were making this up, but I am not that creative.

Yes, cancer cells are technically immortal. Also, for this elixir to “work”, a continuous regimen of antibiotics and steroids needs to be taken indefinitely!

On January 27, the press brought this great news for the immortality seekers: “In major test for longevity field, FDA greenlights study on a ‘near total reset’ of cells”.

Life Biosciences, a biotech startup co-founded by Harvard biologist David Sinclair, got the FDA’s permission to begin a clinical study of its gene therapy designed to rewind the clock on dying cells.

Life Bio calls its approach partial epigenetic reprogramming, and its clinical trial will be the first to test the concept in humans. It falls under the broader umbrella of experimental therapies known as cellular rejuvenation, which is a major focus of several well-funded startups backed by tech executives.

Ok, right away, we see the usual made-up meaningless jargon: epigenetics (a narrative rescue device for failure of 97% of genome to “code” for anything) and calling the toxic gene therapy class “cellular rejuvenation”. Of course it is…